CI
FBRX icon

Cowen Inc’s Forte Biosciences FBRX Stock Holding History

Cowen Inc’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$53K Buy
+61
New +$181K ﹤0.01% 329

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Cowen Inc's FBRX Position: Q2 2019 in Review

Cowen Inc opened a new position in Forte Biosciences (FBRX) in Q2 2019: 17 shares worth $43K. The stake represents ﹤0.01% of the portfolio and ranks #338 among its holdings.

74 funds tracked by Wall St. Rank hold FBRX as of Q2 2019.

  • Cowen Inc held 17 shares of Forte Biosciences worth $43K as of Q2 2019.
  • Forte Biosciences was a new Cowen Inc position in Q2 2019.
  • Forte Biosciences made up ﹤0.01% of Cowen Inc's portfolio in Q2 2019, its #338 holding.
  • 74 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.